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Abstract
Purpose The purpose of this study was to
assess choroidal thickness in migraine
patients during acute migraine attacks and
compare them with healthy controls, using
spectral domain optical coherence
tomography (OCT).
Patients and methods In this prospective
case–control study, choroidal thicknesses of
46 migraine patients during acute migraine
attacks and 46 age- and sex-matched healthy
subjects were measured using a high-speed,
high-resolution frequency domain-OCT
device. All patients underwent a complete
ophthalmic examination before the
measurements. OCT measurements were
taken at the same time of day (0900 hours), in
order to minimize the effects of diurnal
variation.
Results There was a statistically significant
difference in mean choroidal thickness
between the migraine patients during acute
migraine attacks (356.3±21.46mm) and the
controls (302.3±18.34mm; P¼ 0.000). There
were significant differences at all
measurement points (Po0.001 for all).
Conclusion The increased choroidal
thickness of the migraine patients during
acute migraine attacks might be related to
the vascular pathology of the disease.
Further studies are needed to evaluate the
etiopathologic relationship between
choroidal thickness and acute migraine
attack.
Eye (2014) 28, 1477–1481; doi:10.1038/eye.2014.218;
published online 26 September 2014
Introduction
Migraine is a common neurologic syndrome
characterized by recurrent, moderate, or
severely intense headaches that can be uni- or
bilateral. Headache duration changes between
hours and days, and is usually accompanied by
nausea, photophobia, and phonophobia that
worsen by routine physical exertion. Two
competing theories dominate the migraine
pathogenesis discussion. First one, the
vasogenic theory, views migraine as a form of
vascular dysregulation and assumes that the
aura is due to a transient vasoconstriction-
induced hypoxemia.1 Second, the alternative
neurogenic theories, views migraine as a cranial
disorder in which vascular changes are the
result of neuronal dysfunction.2
According to the vasogenic theory, migraine
headache is caused by a rebound vasodilatation
that results in a mechanical depolarization of
primary nociceptive neurons within the walls of
engorged intra- and extracerebral vessels.
Following the early vasoconstrictive stage,
meningeal blood vessels dilate, activating the
trigeminal sensory nerves that surround them,
causing pain. This activation of trigeminal
nerves also causes the release of vasoactive
neuropeptides, further contributing to dilation
and neurogenic inflammation of pain-sensitive
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cranial structures, hence worsening the pain.
In migraine patients with aura, regional cerebral blood
flow reduction starts during the aura and continues
while the headache develops. At a certain point of the
headache phase, regional cerebral blood flow increase to
all level above normal: such an increase may well persist
for a certain time after headache has disappeared.3 These
unstable vascular abnormalities might also affect ocular
blood flow, which can be assessed using color duplex
imaging, laser speckle method, or Doppler flowmetry.4,5
However, because the choroid receives approximately
95% of all ocular blood flow, changes in its structure
could help to evaluate choroidal, thus ocular blood flow.6
In several recent studies, optical coherence tomography
(OCT) was introduced as an effective tool for evaluating
choroidal thickness.7,8 New-generation spectral domain
OCT devices with enhanced scanning speed provide the
opportunity to achieve high-resolution images and
more accurate measurements. Thus, it has become
possible to evaluate ocular tissues located at deeper
levels than that of the retina, which was not possible with
time domain OCT.7,9,10
In this study, we aimed to evaluate the choroidal
thickness of migraine patients during acute migraine
attacks and compare them with that of healthy controls.
Materials and methods
A total of 46 (24 female and 22 male) patients during
acute migraine attacks referred from neurology clinic and
46 age- and gender-matched control (24 female and 22
male) subjects were consecutively enrolled in this study.
The control cases had neither systemic nor ocular
disease, nor any type of headache. To decrease the
control selection bias, every age- and sex-matched
control was consecutively selected after the inclusion of
every eligible migraine patient in the study.
The study was approved by the Baskent University
Institutional Review Board and Ethics Committee. The
research adhered to the tenets of the Declaration of
Helsinki, and a detailed written informed consent form
was obtained before each individual’s participation in
the study. Patients were excluded if they had a history of
ocular surface disorder, previous ocular surgery, or
ocular injury; if they had a history of any systemic
disease that could affect choroidal circulation (such as
hypertension, diabetes, vasculitis, or renal failure); or if
they were using any drug including analgesics,
decongestants, or antihistamines. Moreover, in order to
obtain clear images and to minimize the effect of axial
length on choroidal thickness, patients with best-
corrected visual acuity worse than 20/20 and a refractive
error higher than 1D were excluded from the study.11
All patients underwent a detailed ophthalmic
examination, including visual acuity testing, refraction
assessment, biomicroscopy, intraocular pressure
measurement with non-contact tonometry, fundus
examination, and choroidal thickness measurements by
OCT. OCT scans were performed for each patient during
the peak period of migraine attack. Headache pain
intensity was measured on a four-point scale, where
0¼no headache; 1¼mild headache; 2¼moderate
headache; 3¼ severe headache. This scale is
recommended for use in migraine research by the
International Headache Society.12 The patients were
asked to grade their headaches according to this scale
and called for OCT scans during a period of severe
headache. All patients had bilateral headaches. To ensure
consistency, only one eye of each patient (the right eye)
was included. OCT scans were performed at the same
time of day (09:00 hours) to minimize the effects of
diurnal variation on choroidal thickness.13
All OCT scans were obtained with a high-speed, high-
resolution Fourier domain OCT device (l¼ 840 nm,
26 000 A-scans/s, and 5mm axial resolution) with
Optovue RTVue software version 3.5 (Optovue Inc.,
Fremont, CA, USA). The choroidal thickness
measurements were performed as follows: the scan
pattern was the retina cross-line, which consists of two
orthogonally oriented 6-mm lines containing 1024
A-scans. By automatically inverting the image, the
chorioretinal interface became adjacent to the zero delay.
The retina cross-line scan averages 32 frames, 16 per
direction, without tracking.14 Each B-scan image is
constructed from a number of repeated scans to reduce
speckle noise and improve contrast; typical acquisition
time of a constructed B-scan image is 1.25 s. Choroidal
thickness was measured using a built-in caliper tool
adjusted perpendicularly from the outer edge of the
retinal pigment epithelium to the choroid–sclera
boundary at the fovea and at six other points, located at
1500 mm temporal to the fovea, 1000 mm temporal to the
fovea, 500 mm temporal to the fovea, 500 mm nasal to the
fovea, 1000mm nasal to the fovea and 1500 mm nasal to
the fovea (Figure 1).
Two masked technicians performed the choroidal
thickness measurements. The average of the two
measurements was used; the differences between
readings of the masked physicians were found to be
within 10 mm of the mean. If the measurements did not
agree within 10 mm, then they were repeated, and if the
inconsistency persisted, a third masked reader (FCE)
took a measurement. The interexaminer reproducibility
of the choroidal thickness measurements was assessed by
measuring the intraclass correlation coefficient (ICC).
Statistical analysis was performed with SPSS for
Windows 11.6 (SPSS Inc., Chicago, IL, USA). Data were
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analyzed by independent sample T-test, and to quantify
the reproducibility of manual re-measurements of the
choroidal thickness in cases of alignment errors, the ICC
was calculated. P value o0.05 was considered
statistically significant.
Results
The mean age of the migraine patients was 32±9.7 years
(range¼ 18–61 years), and that of the controls was
33.2±7.1 years (range¼ 18–61 years). There was no
statistically significant difference in age between the
groups (P¼ 0.854).
The mean choroidal thickness was measured as
302.3±18.34mm in the control group and
356.3±21.46mm in the migraine patients during acute
migraine attack. The mean choroidal thickness was
statistically significant between groups (P¼ 0.000).
Moreover, as shown in Table 1, the choroidal thicknesses
of the patients during acute migraine attacks were all
thicker than those of the controls in all eyes and at all
seven measurement points.
The interexaminer ICC for the mean choroidal
thickness was 0.938 (95% CI¼ 0.908–0.985) and ICC was
greater than 0.90 for all measurement points. Table 2
shows the comparison of the mean choroidal thickness
measurements by two different observers in patients
with acute migraine attack and control groups.
Discussion
The current study is a case–control study comparing
subfoveal choroidal thickness between migraine patients
during acute migraine attacks and healthy subjects. This
study demonstrated the mean choroidal thickness was
significantly thicker in the eyes of patients during acute
migraine attacks than that of the controls. These results
suggest that choroidal thickness might be correlated with
ocular blood flow, which in turn might be affected by
rebound vasodilatation in patients with migraine in the
acute attack period.1,15
Cranial blood vessels thus seem to be important
players in the pathophysiology of migraine. In a recent
study by Asghar et al,15 it was shown that migraine is
associated with dilatation of extra and intracerebral
arteries and the headache location is associated with the
location of the vasodilatation. Furthermore, contraction
of both extracerebral and intracerebral arteries is
associated with amelioration of headache.
To date, no method has been defined as the ‘gold
standard’ for evaluating choroidal blood flow.13 Since
Figure 1 Example of choroidal thickness measurements. T-1500: Choroidal thickness at 1500mm temporal to the fovea; T-1000:
Choroidal thickness at 1000mm temporal to the fovea; T-500: Choroidal thickness at 500mm temporal to the fovea; F: Choroidal
thickness at fovea; N-500: Choroidal thickness at 500mm nasal to the fovea; N-1000: Choroidal thickness at 1000mm nasal to the fovea.
Table 1 Mean choroidal thickness measurements in patients
with acute migraine attack and control subjects
Migraine patients
during acute migraine attack
Mean±SD(mm)
Control subjects
Mean±SD (mm)
P value
N-1500 361.53±27.22 305.23±28.24 0.00
N-1000 356.92±21.94 302.23±19.95 0.00
N-500 358.38±18.94 301.23±21.24 0.00
F 362.76±21.23 313.38±23.76 0.00
T-500 367.15±26.37 318.01±25.88 0.00
T-1000 361.03±23.34 305.42±20.81 0.00
T-1500 365.42±26.71 310.03±24.52 0.00
N-1500: Choroidal thickness at 1500 mm nasal to the fovea; N-1000:
Choroidal thickness at 1000 mm nasal to the fovea; N-500: Choroidal
thickness at 500 mm nasal to the fovea; F: Choroidal thickness at fovea;
T-500: Choroidal thickness at 500 mm temporal to the fovea; T-1000:
Choroidal thickness at 1000 mm temporal to the fovea; T-1500: Choroidal
thickness at 1500 mm temporal to the fovea.
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their introduction in 2006, Fourier spectral domain OCT
devices have provided high-speed scanning and high-
resolution images; therefore, an extremely vascular and
dynamic tissue, such as the choroid, can be more
accurately investigated.7,16 As a highly vascular ocular
structure, the choroid is directly influenced by
intraocular and perfusion pressure; therefore its real-time
high-definition images are more likely to demonstrate
the real-time vascular status of this tissue in vivo.16
In previous studies, sildenafil citrate has been reported
to increase choroidal thickness due to a vasodilatory
effect of sildenafil citrate on the choroidal circulation.17
This correlation was further investigated by Kim et al18
using swept-scan high-frequency digital ultrasound to
measure the ocular blood flow. In addition, in a latter
study by Ulas¸ et al,19 significant choroidal thinning was
noted in chronic renal failure patients after hemodialysis.
It is also reported in another recent study by Rishi et al20
that the choroidal thickness in eyes with polypoidal
choroidal vasculopathy was found to be higher than the
normal value, which leads to the argument that high
mean ocular perfusion pressure could possibly have a
role in the etiology of the disease. Moreover, in a recent
study, cigarette smoking has been shown to be related
with choroidal thickness decrease in otherwise healthy
subjects.21
Komatsu et al22 evaluated 101 migraine patients during
headache-free periods with the second derivative of the
fingertip photoplethysmography (SDPTG) waveform
and showed that migraine was complicated by
peripheral circulation disorders of a vasoconstrictive
nature in the attack-free period. In this study, we
evaluated the choroidal thickness of migraine patients
during the acute migraine attack period with OCT and
found choroidal thickness is thicker than that of the
controls, which in turn might be affected by rebound
vasodilatation in migraine patients during an acute
attack period.
There are several restrictions regarding our study, the
main one being the low number of patients. A larger
cohort would have allowed more meaningful analysis on
the relation between the severity of acute migraine
attacks and choroidal thickness; however, this can be
achieved in a further study based on the preliminary
findings of this study. Moreover, the design of the study
with age- and sex-matched control group makes the
results more valuable. The second limitation is the effect
of diurnal rhythm of choroidal thickness (a change of
approximately 20–30 mm), which was demonstrated in
previous studies.13,22 To overcome this limitation and
strengthen our study, the OCT examinations were
performed at the same time of the day (0900 hours). The
third limitation is that we analyzed only the patients with
bilateral headaches. Also evaluation of patients with
unilateral headaches and comparing the choroidal
thicknesses of the eyes with each other in other studies
with larger groups will give us a more definite
conclusion. The last major limitation of this study is the
fact that the choroidal thickness measurements had to be
performed manually using the ‘caliper function’, which
remains a potential cause for interobserver bias. To partly
overcome this limitation, we have used seven different
measurement points of each linear dimension and
measured the thickness of the choroid via manual
segmentation by two independent operators. In the
future, reliable automated segmentation software for the
sclera–choroidal interface may eliminate significant
differences between graders.
Despite these limitations, to the best of our knowledge,
our study is the first to investigate choroidal thickness in
migraine patients during an acute attack period. Further
studies with larger groups (with unilateral and bilateral
Table 2 Comparison of the mean choroidal thickness measurements of the migraine patients with acute migraine attack and control
subjects between two different observers
Migraine patients during
acute migraine attack
Obsever 1
Mean±SD (mm)
Migraine patients during
acute migraine attack
Obsever 2
Mean±SD (mm)
Control subjects
Obsever 1
Mean±SD (mm)
Control subjects
Obsever 2
Mean±SD (mm)
N-1500 361.53±27.22 360.47±24.41 305.23±28.24 304.23±21.23
N-1000 356.92±21.94 357.34±23.42 302.23±19.95 304.27±23.15
N-500 358.38±18.94 357.33±21.66 301.23±21.24 300.94±208.03
F 362.76±21.23 363.37±23.17 313.38±23.76 315.65±25.05
T-500 367.15±26.37 366.11±22.55 318.01±25.88 317.13±23.78
T-1000 361.03±23.34 363.12±28.39 305.42±20.81 306.77±19.94
T-1500 365.42±26.71 363.51±22.43 310.03±24.52 311.13±22.13
N-1500: Choroidal thickness at 1500 mm nasal to the fovea; N-1000: Choroidal thickness at 1000 mm nasal to the fovea; N-500: Choroidal thickness at
500 mm nasal to the fovea; F: Choroidal thickness at fovea; T-500: Choroidal thickness at 500 mm temporal to the fovea; T-1000: Choroidal thickness at
1000 mm temporal to the fovea; T-1500: Choroidal thickness at 1500 mm temporal to the fovea.
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headaches) and longer follow-up periods are necessary
to come to a more definite conclusion.
Summary
What was known before
K The purpose of this study was to assess choroidal
thickness in migraine patients during acute migraine
attacks and compare them with healthy controls, using
spectral domain optical coherence tomography (OCT).
What this study adds
K The increased choroidal thickness of the migraine patients
during acute migraine attacks might be related to the
vascular pathology of the disease.
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